Annovis Bio Inc. (ANVS) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Annovis Bio Inc.

    NYSE: ANVS · Real-Time Price · USD
    2.38
    0.07 (3.03%)
    At close: Sep 11, 2025, 3:56 PM
    2.31
    -0.43%
    Pre-market: Sep 11, 2025, 09:00 AM EDT

    Annovis Bio Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 n/a n/a n/a n/a
    Gross Profit
    		 n/a n/a n/a n/a
    Operating Income
    		 -26.7M -45.03M -25.51M -14.54M
    Interest Income
    		 331.85K 667.9K 182.71K 13.34K
    Pretax Income
    		 -24.59B -56.2M -25.33M -14.49M
    Net Income
    		 -24.59B -56.2M -25.33M -14.49M
    Selling & General & Admin
    		 6.7M 6.24M 9M 6.06M
    Research & Development
    		 20M 38.79M 16.52M 8.48M
    Other Expenses
    		 1K n/a -1K -37K
    Operating Expenses
    		 26.7M 45.03M 25.51M 14.5M
    Interest Expense
    		 1.85M n/a n/a n/a
    Selling & Marketing Expenses
    		 100K n/a n/a n/a
    Cost & Expenses
    		 26.7M 45.03M 25.51M 14.5M
    Income Tax Expense
    		 n/a n/a n/a -50.09K
    Shares Outstanding (Basic)
    		 12.18M 9.02M 8.16M 7.63M
    Shares Outstanding (Diluted)
    		 12.23M 9.02M 8.16M 7.63M
    EPS (Basic)
    		 -2.02K -6.23 -3.1 -1.9
    EPS (Diluted)
    		 -2.01K -6.23 -3.1 -1.9
    EBITDA
    		 -22.74M -45.03M -25.33M -14.5M
    EBIT
    		 -22.74M -45.03M -25.33M -14.49M
    Depreciation & Amortization
    		 n/a n/a 25.51M 14.54M

    Add to Watchlist